NO153011C - Fremgangsmaate ved fremstilling av trestatin a, b og c. - Google Patents

Fremgangsmaate ved fremstilling av trestatin a, b og c.

Info

Publication number
NO153011C
NO153011C NO790469A NO790469A NO153011C NO 153011 C NO153011 C NO 153011C NO 790469 A NO790469 A NO 790469A NO 790469 A NO790469 A NO 790469A NO 153011 C NO153011 C NO 153011C
Authority
NO
Norway
Prior art keywords
trestatin
procedure
preparation
Prior art date
Application number
NO790469A
Other languages
English (en)
Norwegian (no)
Other versions
NO153011B (no
NO790469L (no
Inventor
Yasuji Suhara
Kiyoshi Ogawa
Kazuteru Yokose
Kimihiro Watanabe
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO790469L publication Critical patent/NO790469L/no
Publication of NO153011B publication Critical patent/NO153011B/no
Publication of NO153011C publication Critical patent/NO153011C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/99—Enzyme inactivation by chemical treatment
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
NO790469A 1978-02-14 1979-02-13 Fremgangsmaate ved fremstilling av trestatin a, b og c. NO153011C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB583478 1978-02-14

Publications (3)

Publication Number Publication Date
NO790469L NO790469L (no) 1979-08-15
NO153011B NO153011B (no) 1985-09-23
NO153011C true NO153011C (no) 1986-01-02

Family

ID=9803510

Family Applications (1)

Application Number Title Priority Date Filing Date
NO790469A NO153011C (no) 1978-02-14 1979-02-13 Fremgangsmaate ved fremstilling av trestatin a, b og c.

Country Status (26)

Country Link
US (1) US4273765A (xx)
EP (1) EP0003616B1 (xx)
JP (1) JPS54163511A (xx)
AR (1) AR219150A1 (xx)
AT (1) AT367451B (xx)
AU (1) AU527318B2 (xx)
CA (1) CA1121290A (xx)
DE (2) DE2905649A1 (xx)
DK (1) DK149599C (xx)
ES (1) ES477653A1 (xx)
FI (1) FI63062C (xx)
FR (1) FR2416901A1 (xx)
GR (1) GR72817B (xx)
HU (1) HU181442B (xx)
IE (1) IE47916B1 (xx)
IL (1) IL56626A0 (xx)
LU (1) LU80906A1 (xx)
MC (1) MC1253A1 (xx)
NL (1) NL7901182A (xx)
NO (1) NO153011C (xx)
NZ (1) NZ189625A (xx)
PH (1) PH15084A (xx)
PT (1) PT69218A (xx)
SE (1) SE7901276L (xx)
YU (1) YU41437B (xx)
ZA (1) ZA79528B (xx)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3166093D1 (en) * 1981-01-05 1984-10-18 Takeda Chemical Industries Ltd N-substituted pseudo-aminosugars, their production and use
JPS57146713A (en) * 1981-03-09 1982-09-10 Akira Endo Hypoglycemic
US4595678A (en) * 1982-03-19 1986-06-17 Takeda Chemical Industries, Ltd. N-substituted pseudo-aminosugars and pharmaceutical compositions containing same
US4762857A (en) * 1986-05-30 1988-08-09 E. I. Du Pont De Nemours And Company Trehalose as stabilizer and tableting excipient
US4678812A (en) * 1986-05-30 1987-07-07 E. I. Du Pont De Nemours And Company Trehalose as stabilizer and tableting excipient
US4885361A (en) * 1987-07-31 1989-12-05 Hoffmann-La Roche Inc. Sulfated oligosaccharides
ATE132269T1 (de) * 1990-11-30 1996-01-15 Monoclonetics Int Verfahren zur diagnose chronischer niedriger rückenschmerzen und nackenschmerzen
TW381025B (en) * 1993-08-05 2000-02-01 Hoffmann La Roche Pharmaceutical composition containing a glucosidase inhibitor and a lipase inhibitor
PT1157696E (pt) * 2000-05-24 2007-01-31 Pfizer Tratamento da acidose ruminal com inibidores da alfa-amilase
US7022684B2 (en) * 2000-05-24 2006-04-04 Pfizer Inc. Treatment of rumen acidosis with α-amylase inhibitors
KR20060109926A (ko) 2003-11-19 2006-10-23 메타베이시스 테라퓨틱스, 인크. 새로운 인-함유 갑상선 호르몬 모방약들
US7262318B2 (en) * 2004-03-10 2007-08-28 Pfizer, Inc. Substituted heteroaryl- and phenylsulfamoyl compounds
US20050288340A1 (en) * 2004-06-29 2005-12-29 Pfizer Inc Substituted heteroaryl- and phenylsulfamoyl compounds
ATE439347T1 (de) * 2004-11-23 2009-08-15 Warner Lambert Co 7-(2h-pyrazol-3-yl)-3,5-dihydroxy-heptansäure- derivate als hmg-co-a-reductase-inhibitoren zur behandlung von lipidemia
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
ATE547394T1 (de) 2006-12-01 2012-03-15 Bristol Myers Squibb Co N-((3-benzyl)-2,2-(bis-phenyl)-propan-1- aminderivate als cetp-hemmer für die behandlung von atherosklerose und herz-kreislauf- erkrankungen
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
EA020466B1 (ru) 2007-06-04 2014-11-28 Синерджи Фармасьютикалз Инк. Агонисты гуанилатциклазы, пригодные для лечения желудочно-кишечных нарушений, воспаления, рака и других заболеваний
BRPI0911063A2 (pt) 2008-04-11 2016-11-01 Astellas Pharma Inc composto aminoaçúcar e processo para produção do mesmo
EP2810951B1 (en) 2008-06-04 2017-03-15 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
ES2624828T3 (es) 2008-07-16 2017-07-17 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros
US20120046364A1 (en) 2009-02-10 2012-02-23 Metabasis Therapeutics, Inc. Novel Sulfonic Acid-Containing Thyromimetics, and Methods for Their Use
CA2799708A1 (en) 2010-05-21 2011-11-24 Pfizer Inc. 2-phenyl benzoylamides
US20130156720A1 (en) 2010-08-27 2013-06-20 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
US20130345392A1 (en) 2011-03-04 2013-12-26 Pfizer Inc Edn3-like peptides and uses thereof
MY188344A (en) 2012-03-09 2021-12-01 Biotropics Malaysia Berhad Extract formulations of rhodamnia cinerea and uses thereof
CA2905438A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
CA2905435A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
SG11201507496UA (en) 2013-04-17 2015-11-27 Pfizer N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
PT3004138T (pt) 2013-06-05 2024-06-18 Bausch Health Ireland Ltd Agonistas ultrapuros de guanilato ciclase c, método de produção e utilização dos mesmos
CA2959208C (en) 2014-08-29 2023-09-19 Tes Pharma S.R.L. Pyrimidine derivatives and their use as inhibitors of alpha-amino-beta-carboxymuconate-epsilon-semialdehyde decarboxylase
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
EP3526199B1 (en) 2016-10-14 2022-04-13 Tes Pharma S.r.l. Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase
CA3119509A1 (en) 2018-11-20 2020-05-28 Tes Pharma S.R.L Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxxylase
SG11202107614PA (en) 2019-01-18 2021-08-30 Astrazeneca Ab Pcsk9 inhibitors and methods of use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2064092C2 (de) * 1970-12-28 1983-06-01 Bayer Ag, 5090 Leverkusen Inhibitoren für Glykosidhydrolasen aus Actinomyceten
DE2347782C3 (de) * 1973-09-22 1979-10-11 Bayer Ag, 5090 Leverkusen Aminozuckerderivate, Verfahren zu ihrer Herstellung sowie diese Verbindungen enthaltende Arzneimittel
US4062950A (en) * 1973-09-22 1977-12-13 Bayer Aktiengesellschaft Amino sugar derivatives
US4065557A (en) * 1974-03-21 1977-12-27 Bayer Aktiengesellschaft Amino sugars and their use in improving the meat:fat ratio in animals
USRE29903E (en) 1975-03-19 1979-02-06 American Cyanamid Company Antibacterial antibiotics AM31α, AM31β and AM31γ
DE2614393C3 (de) * 1976-04-02 1980-04-03 Bayer Ag, 5090 Leverkusen Aminozucker-Derivate und diese Verbindungen enthaltende Arzneimittel

Also Published As

Publication number Publication date
SE7901276L (sv) 1979-08-15
PH15084A (en) 1982-07-02
AU527318B2 (en) 1983-02-24
MC1253A1 (fr) 1980-01-14
YU34879A (en) 1983-01-21
FI790486A (fi) 1979-08-15
DE2962165D1 (en) 1982-03-25
YU41437B (en) 1987-06-30
ZA79528B (en) 1980-02-27
PT69218A (en) 1979-03-01
FI63062C (fi) 1983-04-11
FI63062B (fi) 1982-12-31
NL7901182A (nl) 1979-08-16
IE790274L (en) 1979-08-14
NZ189625A (en) 1981-05-01
JPS54163511A (en) 1979-12-26
EP0003616A2 (de) 1979-08-22
DK149599C (da) 1987-06-01
DE2905649A1 (de) 1979-08-16
AT367451B (de) 1982-07-12
LU80906A1 (de) 1980-09-24
IE47916B1 (en) 1984-07-25
EP0003616A3 (en) 1979-09-05
FR2416901B1 (xx) 1980-10-24
ES477653A1 (es) 1980-03-01
DK149599B (da) 1986-08-04
IL56626A0 (en) 1979-05-31
FR2416901A1 (fr) 1979-09-07
HU181442B (en) 1983-07-28
NO153011B (no) 1985-09-23
NO790469L (no) 1979-08-15
US4273765A (en) 1981-06-16
AR219150A1 (es) 1980-07-31
DK61179A (da) 1979-08-15
GR72817B (xx) 1983-12-06
AU4402879A (en) 1979-08-23
JPS643877B2 (xx) 1989-01-23
ATA108879A (de) 1981-11-15
CA1121290A (en) 1982-04-06
EP0003616B1 (de) 1982-02-24

Similar Documents

Publication Publication Date Title
NO153011C (no) Fremgangsmaate ved fremstilling av trestatin a, b og c.
NO790008L (no) Fremgangsmaate ved stoeping av betong.
NO794018L (no) Fremgangsmaate ved fremstilling av polymerer.
NO150512C (no) Fremgangsmaate ved fremstilling av urea.
NO154165C (no) Fremgangsmaate ved fremstilling av 2,3,5-triklorpyridin.
NO155477C (no) Fremgangsmaate ved fremstilling av et konsentrert protrombinkompleks.
NO146540C (no) Fremgangsmaate ved fremstilling av furocumariner.
NO151596C (no) Fremgangsmaate for fremstilling av raffinoermasse fra trefils ved hjelp av en mekanisk-kjemisk-termisk behandling.
NL7900802A (nl) Spuitbus.
NO152894C (no) Fremgangsmaate ved fremstilling av ureapellets.
IT7924973A0 (it) Preparazione aerosolica.
NO152758C (no) Fremgangsmaate ved fremstilling av olefiner.
NO791865L (no) Baandfeste.
NO153431C (no) Fremgangsmaate ved fremstilling av 6alfa-halogen-3-keto-delta1,4-pregnadiener.
NO153853C (no) Fremgangsmaate for fremstilling av 17beta-hydroksy-17alfa-pregn-5-en-21-karboksylsyre-gamma-laktoner.
NO147146C (no) Fremgangsmaate ved fremstilling av alkali- og jordalkalimetallbromider.
IT7925333A0 (it) Accendisigari.
NO147184C (no) Fremgangsmaate ved fremstilling av alkyltiosulfater og arylalkyltiosulfater.
RO75739A (ro) Procedeu pentru prepararea unor carbamoil triazolil-o,n-acetali
NO154837C (no) Fremgangsmaate ved fremstilling av 7-acylindolin-2-oner.
NO154968C (no) Begroningshindrende belegg.
NO153100C (no) Fremgangsmaate ved fremstilling av n-(halogenmethyl)-acylamider.
NO146360C (no) Fremgangsmaate ved fremstilling av 10alfa- og 10beta-methyl-2,9-dioxatricyclo-(4.3.1.03,7)-decaner
NO780651L (no) Fremgangsmaate ved fluorering.
NO153688C (no) Fremgangsmaate for fremstilling av 2-isopropylaminopyrimidin.